Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund Filings: After-Market 13D Watch

Hedge fund filings: After the markets’ close today, we saw a rush of 13D filings come into the SEC. Here’s a brief recap of each.

1) Crestview Acquisition Corp reported a majority ownership in Greenway Medical Technologies, Inc. (NYSE:GWAY).

2) James Roumell and Roumell Asset Management, whom we track, owns shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT). The purpose of today’s filing was to disclose this letter, in which Roumell calls the company’s move to partner with Shin Nippon Biomedical Labs “an astoundingly poor capital allocation decision.”

3) Whitebox Advisors, managed by Andy Redleaf, filed an amended 13D sharing that they own 24.8% of Par Petroleum Corp (OTCMKTS:DPTRQ).


4) Joseph Stilwell, who we’ve covered a lot recently, owns 9.7% of Wayne Savings Bancshares, Inc (NASDAQ:WAYN).

5) Fountainhead Capital Management now owns 65.1% of medical device maker Vycor Medical Inc (OTCMKTS:VYCO).

Disclosure: none

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.